Gordon Mills, M.D., Ph.D., recalls a proposal he wrote 18 years ago
detailing the concept of personalized cancer therapy and its potential
impact. Today, that idea is no longer a proposal, but a reality, and
it's about to get a boost.
Under a new and innovative institutional protocol called Clearing
House, which started in March 2012, scientists are delving deeper into
the biology of patients' tumors, with hopes of identifying...